Anthony Manning
Fortuna: - $ al 31/10/2026
Fortuna: - $ al 31/10/2026
Actualmente, Anthony M. Manning es presidente del Institute For Biomedical Entrepreneurship, Inc. y director científico de Momenta Pharmaceuticals, Inc. El Dr. Manning también forma parte del consejo de administración de Palatin Technologies, Inc. Anteriormente, el Dr. Manning ocupó los cargos de Vicepresidente de Investigación y Desarrollo Preclínico en Aileron Therapeutics, Vicepresidente y Jefe de Investigación de Enfermedades Autoinmunes en Biogen, Jefe de Investigación en Celgene, Vicepresidente y Jefe Global de Inflamación en Roche Pharmaceuticals, Director de Signal Pharmaceuticals y Vicepresidente de Pharmacia Corp. Se doctoró en la Universidad de Otago.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 29/06/2026 | 0 ( -.--% ) | - $ | 31/10/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Director/Miembro de la Junta | 25/07/2023 |
Institute For Biomedical Entrepreneurship, Inc. | Fundador | - |
| Empresas | Cargo | Fin |
|---|---|---|
| REIN THERAPEUTICS INC. | Director Técnico/Científico/I+D | 01/01/2013 |
| BIOGEN INC. | Corporate Officer/Principal | 01/04/2011 |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Corporate Officer/Principal | 01/08/2007 |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Corporate Officer/Principal | 01/01/2002 |
Signal Pharmaceuticals, Inc.
Signal Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical research focused on the discover of new drugs | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Palatin Technologies, Inc.
Palatin Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines based on molecules for the modulation of melanocortin receptor system | Health Technology |
Signal Pharmaceuticals, Inc.
Signal Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biopharmaceutical research focused on the discover of new drugs | Commercial Services |
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
Rein Therapeutics, Inc.
Rein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops stapled peptide drugs | Health Technology |
University of Otago
University of Otago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
Institute For Biomedical Entrepreneurship, Inc. | |
Monte Rosa Therapeutics, Inc.
Monte Rosa Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecular glue degrader medicines for oncology, autoimmune and inflammatory diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.